The Prognostic Role and Diagnostic Efficacy of Exercise Right Heart Catheterization With a Simultaneous Echocardiography in Patients With Dyspnea on Exertion

Recruiting now

Conditions studied: Heart Failure With Preserved Ejection Fraction, Chronic Pulmonary Thromboembolism (Disorder)

In brief

To evaluate the role of exercise hemodynamic testing in the diagnostic workup for patients with dyspnea on exertion referred to the catheterization lab.

Key facts

Study ID

NCT05490901

Run by

Samsung Medical Center

People needed

400

Starts

2020-03-17

Expected to finish

2029-06-30

Last updated by the study team

2022-08-08

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject must be at least 19 years of age.
• Patients with dyspnea on exertion
• Written informed consent of participating subjects after being fully briefed (for prospective analysis)

You may not qualify if…

• Patients with incomplete hemodynamic data at rest or exercise
• Advanced tumor disease or other diseases with a short life expectancy
• Uncontrolled systemic arterial hypertension ( > 160/100 mmHg at rest)
• FEV1<50% predicted
• TLC<60% predicted

Where it is running

• Samsung Medical Center — Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.